AKT1 and Alzheimer disease: Pathways that are known to be involved in AD pathogenesis such as mitogen-activated protein kinase (MAPK), protein kinase B (Akt), and glycogen synthase kinase-3β (GSK-3β) are altered due to insulin dysregulation.